Revenue
$7.7b
-9.3% ↓ vs $8.5b
Operating cash flow held up only because working capital released $473m, masking weaker underlying earnings as the dividend was suspended.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Key metrics
FY24 vs FY23
Revenue
$7.7b
-9.3% ↓ vs $8.5b
EBITDA
$846m
— vs —
Net profit after tax
−$227m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Net cash inflow from operating activities
$398m
+2.6% ↑ vs $388m
Declared dividend per share
—
— vs 16.0c
Operating profit
$176m
-64.6% ↓ vs $497m
Profit before tax
−$24m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Cash and cash equivalents
$311m
-14.8% ↓ vs $365m
What changed
Annolyse's historical baseline classifies the revenue decline as below the normal range against a four-period mean of +1.6%. Of the loss, $141m relates to a disclosed discontinued operation; continuing operations also turned loss-making, with PBT of -$24m versus +$343m and a $79m loss after tax. Operating profit nearly halved to $176m from $497m. EBITDA before significant items was $846m, while reported operating cash flow edged up 2.6% to $398m. Net debt rose to $1.8b from $1.4b, gross borrowings climbed $305m to $2.1b, and equity contracted $349m to $3.3b. ROE swung to -6.5% from +6.6%.
What matters
The $141m discontinued-operation charge accounts for a large part of the headline NPAT swing, but PBT growth of -107.0% on the continuing book shows the trading business itself moved through breakeven. Management's commentary cites EBIT before significant items of $509m versus $785m and a continuing-operations EBIT margin of 6.6% (FY23: 10.2%), with Materials & Distribution activity "materially lower".
Cash generation rests on working-capital release. OCF grew only because operating working capital fell $473m, with trade debtors down $239m and inventories down $210m. Debtor days fell to 30.2, which the supplied historical range classifies as an unprecedented low against a 32.3–37.7-day baseline. Without that receivable compression, cash flow would not have covered $429m of capex.
Leverage moved the wrong way and capital priorities shifted. Net debt rose $359m and the board passed on a final dividend versus 16 cps prior. This matters because it signals the balance sheet now ranks ahead of shareholder distributions for FY25 capital allocation.
Expectations
The HY24 context shows revenue of $4.2b and an NPAT loss of $120m, implying a second-half revenue print of $3.4b and an NPAT loss of $107m. The second half therefore did not deliver a meaningful trading recovery on either line, even though management states the EBIT outcome was within its guidance range. The investor presentation flags "weaker markets" and points to ongoing softness in NZ residential and Materials & Distribution, language that does not point to a near-term rebound. The size of the discontinued-operation charge and the leverage step-up mean any FY25 read needs to weigh further restructuring and remediation costs alongside cyclical recovery.
Quality of result
EBITDA of $846m converted to only $398m of operating cash, a 47.0% conversion ratio, and the gap was bridged by the $473m fall in operating working capital. Receivable days at the supplied unprecedented low of 30.2 indicate the working-capital benefit cannot easily be repeated and could partially reverse if collections normalise back toward the 32.3–37.7 historical range.
Below the line, FCF pre-lease was -$31m on $429m of capex, sitting at the lower edge of the historical range against a four-period mean of $245.5m. The current effective tax rate of -229.2% (FY23: 25.9%) confirms tax has distorted reported NPAT, so PBT growth of -107.0% is the cleaner operating read. Dividend suspension and ROE of -6.5% versus +6.6% reflect that, once the discontinued operation and tax noise are stripped away, underlying returns have moved into negative territory rather than just stepping down.
Unresolved
This briefing cannot assess debt covenant headroom, refinancing schedule, or the likelihood of further impairment or remediation charges without disclosure of debt maturity profile and provisioning detail.
Chat
Ask follow-up questions about Fletcher Building's FY24 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
2024 Annual Report
FY24 / financial reportInvestor Presentation
FY24 / results presentationResults Announcement
FY24 / results announcementStock Exchange Notice
FY24 / results releaseAnnual Report 2023
FY23 / financial reportResults Announcement
FY23 / results announcementResults Announcement
FY23 / results release2024 Interim Financial Results
HY24 / financial reportResults Announcement
HY24 / results announcementResults Announcement
HY24 / results releaseFletcher Building FY24 Results Webcast Details
FY24 / commentaryFletcher Building Market Update
FY24 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Earnings quality and statutory distortions
This result includes a statutory earnings-quality distortion flag.
Cash conversion quality
This result converted 47.0% of EBITDA to operating cash flow.
Leverage and balance-sheet risk
Net debt / EBITDA is 2.12x for this result.
ROE and capital efficiency
ROE was -6.5%, -13.1pp versus the prior comparable period.
Get the next Fletcher Building briefing and related NZX reporting-season updates by email.